Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Leukocyte
DISEASE(S): Acute Leukemia
SUBMITTER: Vinothini Rajeeve
LAB HEAD: Pedro R. Cutillas
PROVIDER: PXD038288 | Pride | 2024-01-26
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
F008515.dat | Other | |||
F008515.mzid.gz | Mzid | |||
F008516.dat | Other | |||
F008516.mzid.gz | Mzid | |||
F008517.dat | Other |
Items per page: 5 1 - 5 of 96 |
Di Mambro Antonella A Arroyo-Berdugo Yoana Y Fioretti Tiziana T Randles Michael M Cozzuto Luca L Rajeeve Vinothini V Cevenini Armando A Austin Michael J MJ Esposito Gabriella G Ponomarenko Julia J Lucas Claire M CM Cutillas Pedro P Gribben John J Williams Owen O Calle Yolanda Y Patel Bela B Esposito Maria Teresa MT
Oncogene 20231027 50
KMT2A-rearranged (KMT2A-R) is an aggressive and chemo-refractory acute leukemia which mostly affects children. Transcriptomics-based characterization and chemical interrogation identified kinases as key drivers of survival and drug resistance in KMT2A-R leukemia. In contrast, the contribution and regulation of phosphatases is unknown. In this study we uncover the essential role and underlying mechanisms of SET, the endogenous inhibitor of Ser/Thr phosphatase PP2A, in KMT2A-R-leukemia. Investigat ...[more]